NEW YORK (GenomeWeb News) - Illumina today reported a 54 percent boost in third-quarter revenue as a profit swung to a loss due to charges associated with its acquisition of sequencing startup Avantome.
 
For the quarter ended Sept. 30, Illumina reported revenues of $150.3 million, a 54 percent increase over $97.5 million in the third quarter of 2007 and its 29th consecutive quarter of revenue growth.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.